The transfer of six internal RNA segments from the avian influenza A/Mallard/New York/6750/78 (H2N2) virus reproducibly attenuates human influenza A viruses for squirrel monkeys and adult humans. To identify the avian influenza A virus genes that specify the attenuation and host range restriction of avian-human (ah) influenza A reassortant viruses (referred to as ah reassortants), we isolated six single-gene reassortant viruses (SGRs), each having a single internal RNA segment of the influenza A/Mallard/New York/6750/78 virus and seven RNA segments from the human influenza A/Los Angeles/2/87 (H3N2) wild-type virus. To assess the level of attenuation, we compared each SGR with the A/Los Angeles/2/87 wild-type virus and a 6-2 gene ah reassortant (having six internal RNA segments from the avian influenza A virus parent and two genes encoding the hemagglutinin and neuraminidase glycoproteins from the wild-type human influenza A virus) for the ability to replicate in seronegative squirrel monkeys and adult human volunteers. In monkeys and humans, replication of the 6-2 gene ah reassortant was highly restricted. In humans, the NS, M, PB2, and PB1 SGRs each replicated significantly less efficiently (P < 0.05) than the wild-type human influenza A virus parent, suggesting that each of these genes contributes to the attenuation phenotype. In monkeys, only the NP, PB2, and possibly the M genes contributed to the attenuation phenotype. These discordant observations, particularly with regard to the NP SGR, indicate that not all genetic determinants of attenuation of influenza A viruses for humans can be identified during studies of SGRs conducted with monkeys. The PB2 and M SGRs that were attenuated in humans each exhibited a new phenotype that was not observed for either parental virus. Thus, it was not possible to determine whether the avian influenza virus PB2 or M gene itself or a specific constellation of avian and human influenza A virus genes specified restriction of virus replication in humans.
The genes of avian influenza A viruses have nucleotide sequences that are significantly different from those of the corresponding genes of human influenza A viruses (1, 24) . The avian strains replicate efficiently in avian hosts but are moderately restricted in their replication in the lower respiratory tracts of nonavian hosts, such as monkeys, and as a consequence they are attenuated in primates (14, 15) . Thus, these viruses possess the properties of host range restriction and attenuation. The A/Mallard/New York/6750/78 (A/Mallard/NY/78) (H2N2) virus, which possesses these phenotypes, has been used as a donor of genes to produce live attenuated avian-human (ah) influenza A reassortant viruses (referred to as ah reassortants) (16 ulent human influenza A viruses for susceptible monkeys and adult humans (2, 9, 11, 13, 16, 25, 28, 29) .
To study the genetic determinants of the avian influenza virus that specify the host range restriction of replication and the attenuation phenotypes of the ah reassortant viruses, we isolated single gene substitution reassortant viruses, referred to as SGRs. Each of these SGRs acquired only one RNA segment from the influenza A/Mallard/NY/78 donor virus and the remaining RNA segments from a human influenza A wild-type virus. We had previously isolated PB1, PA, NP, M, and NS SGRs from the influenza A/Mallard/NY/78 and human influenza A/Udorn/72 parent viruses and demonstrated that the NP and M SGRs were attenuated for squirrel monkeys (33) . In the present study, we generated a second set of six SGRs from the A/Mallard/NY/78 (H2N2) and human influenza A/Los Angeles/2/87 (H3N2) parent viruses for two reasons Viruses were propagated and purified and RNA was extracted as previously described (10) . Purified viral RNA was analyzed by electrophoresis for 18 to 24 h at 100 V and at 0°C with polyacrylamide gels containing 2.6% acrylamide and 6.0 or 5.5 M urea (Fig. 1) . RNA segments were visualized by ammoniacal silver staining (24) .
Sequence analysis. The nucleotide sequence of the polymerase genes was determined by the dideoxynucleotide chain termination technique (23) by using synthetic oligonucleotide primers and genomic virion RNA as described previously (3 Studies with squirrel monkeys. The duration and level of replication of the parental viruses and their reassortant progeny in squirrel monkeys were evaluated as previously described (29, 33 A/Los Angeles/2/87 virus were also measured by kinetic enzyme-linked immunosorbent assay (KELISA) by using a modification of the method of Snyder et al. (26) as previously described (20, 30) . Sera were studied at a final dilution of 1:4,000, and preconcentrated nasal wash specimens were studied at a dilution of 1:8; these dilutions gave KELISA color development rates well within the dynamic range of the assay. Nasal wash specimens were also subjected to protein determinations by using a microplate modification of the BCA assay (Pierce Chemical Co., Rockford, Ill.) (31) , and IgA KELISA rate results were normalized to an arbitrary protein content of 350 ,ug/ml (approximately the median value for all specimens) by using the following formula: normalized KELISA rate = specimen KELISA rate x (350/specimen protein concentration). We defined significant responses in the serum IgG KELISA by simultaneously studying the screening serum specimen which established volunteer eligibility and the immediate preinoculation serum specimen. These specimens covered an interval of 1 to 2 months outside the influenza virus epidemic season and therefore reflect short-term variability in influenza A/Los Angeles/2/87 virus KELISA reactivity in a given individual not exposed to antigen. For each subject, a ratio of the two results was derived; the ratios were transformed to logarithmic values. The mean plus two standard deviations were calculated, and the antilog of this value (1.23) was set as the upper limit of the ratio between a pre-and postinoculation specimen above which a significant response was said to have occurred.
Lacking a screening nasal wash specimen, we generated an upper limit for the nonspecific variability of normalized IgA responses by a method similar to that outlined for sera by Snyder et al. (26) . All possible normalized values, based on duplicate protein and triplicate KELISA rate determinations, were generated for each specimen. The distribution of possible ratios between these values was then characterized as above, and an upper limit (1.80) for ratios between repeated determinations on the same specimen was calculated. Increases of more than 1.8-fold between pre-and postinoculation normalized nasal wash IgA KELISA rates were thus considered significant. Nasal wash specimens for virologic study were collected before virus inoculation and daily for the duration of observation. The method used for virus inoculation and isolation from MDCK cells was published previously (11) . For monkeys and humans administered with the PB2 SGR, specimens for virus quantitation were inoculated into 9-day-old embryonated eggs (Truslow Farms, Chestertown, Md.). After incubation at 32°C for 3 days, the allantoic fluid was tested for hemagglutination activity. Isolation of virus from nasal wash specimens and/or a significant increase in influenza virus-specific antibody titer was considered evidence of infection. (Table 1) . We also sought to confirm the origin of the polymerase genes in clone 224 of the A/Pintail/Alberta/119/79 x A/Washington/897/80 mating (27) , which also has a host range phenotype of restricted replication identical to that of the PB2 SGR isolated in the present study. We previously reported that clone 224 had received the avian PB1 gene and the human PB2 and PA genes (27) (Table 2 ). In contrast, the ah reassortant containing six internal avian RNA segments was attenuated, as shown by its greatly reduced replication in both the upper and lower respiratory tracts. The level of replication of each A/Los Angeles/2/87 x A/Mallard/NY/78 SGR virus in the nasopharynges and tracheas was then compared with that of the wild-type virus parent to assess the degree of growth restriction specified by the internal avian influenza virus gene ( PA gene does not specify attenuation a Normal plaque size in PCK cells ranged from a diameter of 2.4 to 3.5 mm, whereas the diameter of the small plaques of the M SGR was on average 1.75 mm. b Attenuation (indicated on a scale of 0 to + +) was denoted by restriction of virus replication of ah reassortants compared with that of wild-type virus. ' The NP gene single gene reassortant also specified restriction in virus replication in squirrel monkeys in a previous study (14) . d The M gene single gene reassortant specified greater restriction of replication in a previous study (14) than in the present study.
wild-type virus. The PB2 and M SGRs and the 6-2 gene ah reassortant failed to replicate to detectable levels in the upper respiratory tracts of volunteers, suggesting that the PB2 and M SGRs were fully attenuated for humans. Compared with the duration and peak titer of wild-type virus shed, the NS, PB1, PB2, and M SGRs each replicated significantly less (P < 0.02) and for a shorter period (P < 0.05). Since the PB1, PA, and NS SGR viruses replicated to a higher titer than the 6-2 gene ah reassortant virus, the acquisition of each of these genes apparently conferred only partial attenuation to the wild-type virus.
DISCUSSION
Two previous studies of ah reassortant (27, 33) . Studies with squirrel monkeys (33) also showed that the NS gene of the A/Mallard/NY/78 virus, which had been assigned by nucleotide sequence analysis to the A allele of the influenza virus NS RNA segment (34) , did not exert an attenuating effect on the human influenza A wild-type virus for squirrel monkeys. On the basis of the findings with squirrel monkeys, it was predicted that the NP gene would be a major genetic determinant of restriction of replication of ah influenza A reassortant viruses in the respiratory tracts of humans and the NS gene would not be expected to affect viral replication (27, 33) . Therefore, we were surprised to find in the present study that the levels of replication of the NP and NS SGRs derived from the A/Mallard/NY/78 donor virus and the A/Los Angeles/2/87 wild-type virus in the respiratory tracts of squirrel monkeys and humans were opposite ( (30) . This more efficient interaction with the proteins of the HlNl wild-type virus resulted in enhanced replication and the mild, but unacceptable, reactogenicity of the HlNl ah reassortant that was observed previously (30) . Evidence from the present study that the NP gene is not responsible for the attenuation of human influenza A wild-type virus for humans led to further clarification of the mechanism responsible for the enhanced reactogenicity. It is now suggested that the interaction between the A/Mallard/NY/78 M protein and the surface glycoproteins of the HlNl wild-type virus may have led to a more efficient budding process, resulting in a higher level of replication of the HlNl ah reassortant virus and a higher frequency of illness.
In the present study, the M and PB2 SGRs, both of which were highly attenuated in humans, expressed phenotypes in vitro that were not shown by either parental virus or the other reassortant viruses. The 
